InvestorsHub Logo
Followers 156
Posts 6362
Boards Moderated 1
Alias Born 08/06/2004

Re: MayoMobile post# 375474

Wednesday, 09/28/2022 2:20:17 PM

Wednesday, September 28, 2022 2:20:17 PM

Post# of 460256
AVXL Due Diligence for new eyes and reference material for old eyes - 8 Sources:

Update Compendium, a 3rd party independent review and projections with data and sources.
Projected Blarcamesine Revenues & Market Cap; plus a wealth of other data and important details. Compiled by Mayo:
https://www.sotcanalytics.com/update-compendium

Jun 2022 Commentary on Anavex's First Educational Video.
A report from various members of the company management team on current operations and future projections:
https://www.anavex.com/vnrjune2022

NEWS: Anavex Announces First Entire Clinical Alzheimer’s Gene Pathway Data of ANAVEX®2-73 at AAIC 2022
https://www.anavex.com/post/anavex-announces-first-entire-clinical-alzheimer-s-gene-pathway-data-of-anavex-2-73-at-aaic-2022

Corporate Slides.
Very useful for a visual look at all the Anavex programs, trials, graphs, and useful data:
https://www.anavex.com/_files/ugd/850d88_6d847f744209465f82a4ad655bb25941.pdf

Piotrpeterblog.com is an independent analysis blog on Alzheimer and CNS Drugs.
https://piotrpeterblog.com/

An extensive list of a wide range of various topics with links, compiled DD, and recent posts. Compiled by XenaLives
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166917727

A report given by Dr. Randi Hagerman, a recognized leader WW for CNS conditions and treatments. Compiled by tradeherpete.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168422630

Anavex Company, an Overview; compiled by Mayo Mobile:
https://drive.google.com/file/d/15i9suShnAjC_Vq5gEl-ocp3ebsWKr0fd/view

Good luck with the DD, feel free to ask the knowledgeable board any questions.
RedShoulder

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News